sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
23-Jul-2016 17:27
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 51-75 out of 1286.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

Public Release: 29-Jun-2016
Journal of Infectious Diseases
Analysis of 1976 Ebola outbreak holds lessons relevant today
With the recent Ebola epidemic in West Africa reviving interest in the first outbreak of the deadly hemorrhagic fever 40 years ago, scientists led by Dr. Joel Breman of the Fogarty International Center at the National Institutes of Health have published a report in The Journal of Infectious Diseases that highlights lessons learned from the smaller, more quickly contained 1976 outbreak.

Contact: Ann Puderbaugh
ann.puderbaugh@nih.gov
301-496-2075
NIH/Fogarty International Center

Public Release: 29-Jun-2016
Gene Drive Technology: Where is the future?
For this episode of BioScience Talks, we're joined by Gene Drive Committee co-chair James P. Collins of Arizona State University and committee member Joseph Travis of Florida State University. They fill us in on the specifics of the new committee report and on the future of gene drives.

Contact: James M Verdier
jverdier@aibs.org
205-286-8626
American Institute of Biological Sciences

Public Release: 28-Jun-2016
Journal of Medical Entomology
Free articles on Aedes albopictus, mosquitoes that may transmit Zika
Oxford University Press and the Entomological Society of America have released a special collection of free articles on the Asian tiger mosquito (Aedes albopictus).

Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America

Public Release: 28-Jun-2016
Scientific Reports
Doing the math on Zika and sex
A University of Miami math professor has developed a scientific model to address the various ways the Zika virus proliferates. The study, published June 17 in Scientific Reports, reveals that mosquito control should remain the most important mitigation method to control the virus. However, the study reveals that Zika is a complicated virus and sexual transmission increases the risk of infection and prolongs the outbreak.

Contact: Alexandra Bassil
a.bassil@miami.edu
305-284-1092
University of Miami

Public Release: 28-Jun-2016
CIP sweetpotato scientists awarded World Food Prize for combatting vitamin A deficiency
The World Food Prize, announced that the 2016 World Food Prize will be awarded to three International Potato Center (CIP) Scientists, Drs. Jan Low, Maria Andrade, and Robert Mwanga and HarvestPlus' Dr. Howarth Bouis in recognition of their combined success in improving nutrition and health through biofortified crops.

Contact: Joel Ranck
j.ranck@cgiar.org
51-194-189-3063
International Potato Center / Centro Internacional de la Papa

Public Release: 28-Jun-2016
Nature
New preclinical study indicates vaccine to prevent Zika infection in humans is feasible
The Walter Reed Army Institute of Research (WRAIR) and collaborators at the Beth Israel Deaconess Medical Center and Harvard Medical School have completed a promising preclinical study of two Zika vaccine candidates that suggests that an effective human vaccine will be achievable. Findings from the study were published today in the journal Nature.
National Institutes of Health, Ragon Institute of MGH, MIT and Harvard, Sao Paulo Research Foundation

Contact: Debra Yourick
debra.l.yourick.civ@mail.mil
301-319-9471
The U.S. Military HIV Research Program (MHRP)

Public Release: 28-Jun-2016
Nature Communications
Monkey study shows Zika infection prolonged in pregnancy
University of Wisconsin-Madison researchers studying monkeys have shown that one infection with Zika virus protects against future infection, though pregnancy may drastically prolong the time the virus stays in the body.

Contact: David O'Connor
dhoconno@wisc.edu
608-301-5710
University of Wisconsin-Madison

Public Release: 28-Jun-2016
Researcher receives grant to understand why some HIV+ individuals avoid 'duet of death'
Case Western Reserve University School of Medicine experts and colleagues in the United States and Africa have received an $11 million, five-year NIH grant to understand why some people living with HIV in Africa avoid becoming infected with the bacterium that causes tuberculosis (TB) despite exposure to high-TB-risk circumstances.
National Institutes of Health, Fogarty International Center

Contact: Marc Kaplan
marc.kaplan@case.edu
216-368-4692
Case Western Reserve University

Public Release: 27-Jun-2016
PLOS Neglected Tropical Diseases
Mobile, phone-based microscopes work well in the field with minimal training
Handheld, mobile phone-based microscopes can be used in developing countries after minimal training of community laboratory technicians to diagnose intestinal parasites quickly and accurately.
Grand Challenges Canada

Contact: Alexandra Radkewycz
Alexandra.Radkewycz@uhn.ca
416-340-3895
University Health Network

Public Release: 27-Jun-2016
Nature Genetics
Monitoring malaria parasite reveals evolving drug resistance and infection history
Scientists have discovered that the malaria parasite Plasmodium vivax is evolving rapidly to adapt to conditions in different geographical locations, in particular to defend itself against widely-used antimalarial drugs. The study, published in Nature Genetics today, provides a foundation for using genomic surveillance to guide effective strategies for malaria control and elimination.
The Wellcome Trust, Medical Research Council, UK Department for International Development, Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS, others

Contact: Samantha Wynne
press.office@sanger.ac.uk
122-349-2368
Wellcome Trust Sanger Institute

Public Release: 23-Jun-2016
Nature
Antibodies that are effective against both dengue and Zika viruses
Scientists from the Institut Pasteur and the CNRS, in collaboration with Imperial College London and the University of Vienna, Austria, have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus. The description of the binding site for these antibodies on the viral envelope, identical for both viruses, could lead to the development of a universal vaccine that offers simultaneous protection against dengue and Zika virus disease.
European Framework Programme DENFREE, Integrative Biology of Emerging Infectious Diseases LabEx, FlaviStem Grant

Contact: Myriam Rebeyrotte
presse@pasteur.fr
Institut Pasteur

Public Release: 23-Jun-2016
New England Journal of Medicine
Malaria -- a mapping of artemisinin resistance confirms that resistance is confined to Asia
The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falciparum malaria is for the moment confined to Southeast Asia and has not spread to sub-Saharan Africa. Led by researchers from both the Institut Pasteur in Paris and the Institut Pasteur in Cambodia, KARMA gathers a large consortium of institutions including 13 members of the Institut Pasteur International Network.
World Health Organization

Contact: Myriam Rebeyrotte
presse@pasteur.fr
Institut Pasteur

Public Release: 23-Jun-2016
Cancer Prevention Research
Broccoli sprout extract may protect against oral cancer recurrence
Potent doses of broccoli sprout extract activate a 'detoxification' gene and may help prevent cancer recurrence in survivors of head and neck cancer, according to a 'green chemoprevention' trial by the University of Pittsburgh Cancer Institute, partner with UPMC CancerCenter. It is the first study demonstrating that the extract protects against oral cancer, with the results of human, animal and laboratory tests reported today.
NIH/National Cancer Institute, Lewis B. and Dorothy Cullman Foundation

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 23-Jun-2016
PLOS Neglected Tropical Diseases
Evaluation of commercially sold rapid rabies tests reveals serious problems with accuracy
Rabies virus (RABV) transmitted by dogs is responsible for an estimated 60,000 human deaths per year, especially in Asia and Africa. A study published in PLOS NTDs reports that six commercially available rapid rabies tests -- which could make testing dogs much easier -- fail to reproducibly yield accurate results.
Friedrich Loeffler Institute

Contact: Conrad Freuling
Conrad.Freuling@fli.bund.de
49-038-351-71660
PLOS

Public Release: 22-Jun-2016
Scientific Reports
New targeted drug effectively dissolves blood clots, has fewer side effects
The main objective of emergency assistance in critical conditions associated with the blockage of blood vessels is to quickly dissolve the clot. To this end, Russian scientists have developed a magnetically controlled drug that can be condensed on a blood clot by means of a magnetic field and can dissolve clots up to 4,000 times more efficiently than ordinary enzyme-based drugs. The new study will also help reduce drug dosage, thus avoiding numerous side effects.
Russian Science Foundation

Contact: Dmitry Malkov
dvmalkov@corp.ifmo.ru
7-953-377-5508
ITMO University

Public Release: 21-Jun-2016
Vaccine
Drones could be cheaper alternative to delivering vaccines in developing world
Using unmanned drones to deliver vaccines in low- and middle-income countries may save money and improve vaccination rates, new research led by the Johns Hopkins Bloomberg School of Public Health and the Pittsburgh Supercomputing Center suggests.
Bill and Melinda Gates Foundation, Agency for Healthcare Research and Quality, NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 20-Jun-2016
Just how gestational diabetes puts babies at lifelong risk for cardiovascular disease, under study
Gestational diabetes can put babies at a lifelong risk for cardiovascular disease, and scientists want to better understand how.
NIH/National Institute of Child Health and Human Development

Contact: Toni Baker
tbaker@augusta.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 20-Jun-2016
Antimicrobial Agents and Chemotherapy
Stealth nanocapsules kill Chagas parasites in mouse models
Lychnopholide, a substance isolated from a Brazilian plant, and formulated as part of 'nanocapsules' cured more than half of a group of mice that had been infected experimentally with Chagas disease parasites. 'Chagas disease affects millions of people, mainly in poor rural areas of 21 Latin American countries,' said Marta de Lana, Ph.D.

Contact: Aleea Khan
communications@asmusa.org
202-942-9365
American Society for Microbiology

Public Release: 16-Jun-2016
Journal of Health Care Finance
'Disease outbreak guarantees' -- A proposed mechanism for enhancing public health capacity
What if private companies could obtain some coverage to protect their foreign investments in developing countries against crippling infectious disease outbreaks such as Ebola? The possible path to offering disease outbreak guarantees is an idea being posed by two global health researchers who suggest that a mechanism for establishing such an instrument could be tied to public health investments.

Contact: Karen Teber
km463@georgetown.edu
Georgetown University Medical Center

Public Release: 16-Jun-2016
PLOS Neglected Tropical Diseases
Cholera vaccine study in Haiti suggests problems with current booster regimen
Cholera outbreaks are on the rise. To prevent and control them, three oral cholera vaccines are currently approved by WHO. A study published in PLOS NTDs examining the immune response to one of them in Haitian adults finds that while the first vaccine round elicits a strong cholera-specific response in the mucosa (the first point of contact with the cholera pathogen), the booster dose after 2 weeks does not appear to stimulate the immune system further.

Contact: Jason B. Harris
jbharris@mgh.harvard.edu
617-726-3812
PLOS

Public Release: 16-Jun-2016
PLOS Pathogens
Mosquito saliva increases disease severity following dengue virus infection
Insects transmit diseases when, probing for blood vessels, they inject saliva together with viral, bacterial, or parasitic pathogens into the skin of mammalian hosts. A study in mice published on June 16, 2016 in PLOS Pathogens suggests a critical role of mosquito saliva in the outcome of dengue virus infection.

Contact: Michael Schmid
michael.alex.schmid@gmail.com
PLOS

Public Release: 15-Jun-2016
Bioinformatics
Personalized medicine will employ computer algorithms
Russian scientists have developed a software program enabling them to quickly compare sets of DNA of microorganisms living in different environments. The researchers have already suggested exactly how the new program could be applied in practice. Using the algorithm to compare the microflora of a healthy person with the microflora of a patient, specialists would be able to detect previously unknown pathogens and their strains, which can aid the development of personalized medicine. The results of the study have been published in Bioinformatics.
The Government of Russian Federation, Russian Scientific Foundation

Contact: Dmitry Malkov
dvmalkov@corp.ifmo.ru
7-953-377-5508
ITMO University

Public Release: 15-Jun-2016
Celgene joins DNDi's 'Drug Discovery Booster'
The biopharmaceutical company Celgene has become the fifth company to join the 'Neglected Tropical Diseases Drug Discovery Booster' consortium, a new initiative to accelerate and cut the cost of early stage drug discovery for two of the world's most neglected diseases, leishmaniasis and Chagas disease.

Contact: Violaine Dallenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 14-Jun-2016
Journal of the American Heart Association
As Olympics near, study finds low levels of physical activity in Brazil
A large study confirms that physical activity provides Brazilians with significant cardio-metabolic health benefits, but reports that fewer than three in 10 participants are active.
Ministry of Health of Brazil, Brazilian Council of Research, University of São Paolo, American Heart Association, Brown University's Brazil Initiative

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 14-Jun-2016
Clinical Infectious Diseases
Antibiotics against severe salmonella infections in Africa increasingly ineffective
Salmonella infections in the bloodstream, caused by Salmonella enterica bacteria, are still the cause of many deaths in southern regions and Southeast Asia. Children between the age of two and five years are particularly affected. Treating these infections could become a growing problem owing to increasing antibiotic resistance. DZIF scientists from the Bernhard Nocht Institute for Tropical Medicine have now confirmed that even the newer generations of antibiotics are becoming less and less effective.

Contact: Jürgen May
may@bnitm.de
49-404-281-8369
German Center for Infection Research

Showing releases 51-75 out of 1286.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>